Offer - Urjas Oil for just ₹ 1
Myostigmin 2.5 Injection is a prescription drug, available for use as Injection. It is primarily used for the treatment of Myasthenia Gravis. Other than this, Myostigmin 2.5 Injection has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Myostigmin 2.5 Injection. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Myostigmin 2.5 Injection can also lead to other problems, which have been listed below. Normally, these side effects of Myostigmin 2.5 Injection are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Myostigmin 2.5 Injection has a Unknown effect for pregnant women and Mild effect on lactating mothers. In addition, Myostigmin 2.5 Injection's effects on the liver, heart and kidney are discussed below in the Myostigmin 2.5 Injection related warnings section.
Myostigmin 2.5 Injection is not recommended if you suffer from certain medical conditions as it can have adverse effects. Arrhythmia, Peptic Ulcer, Asthma are examples of such conditions. Other conditions have been mentioned below in the Myostigmin 2.5 Injection contraindications section.
Additionally, Myostigmin 2.5 Injection may also adversely react with other medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Myostigmin 2.5 Injection is considered not safe while driving, and is not addictive.
Myostigmin 2.5 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Infant (1 month to 2 years) |
|
| Neonates (0 to 1 month) |
|
Is the use of Myostigmin 2.5 Injection safe for pregnant women?
No research has not been done till date on the safety of Myostigmin for pregnant women. So its effects on pregnant women are unknown.
Is the use of Myostigmin 2.5 Injection safe during breastfeeding?
Side effects of Myostigmin for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Myostigmin 2.5 Injection on the Kidneys?
Myostigmin may have mild side effects on the kidneys.
What is the effect of Myostigmin 2.5 Injection on the Liver?
Myostigmin is completely safe for the liver.
What is the effect of Myostigmin 2.5 Injection on the Heart?
Very few cases of side effects of Myostigmin on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Myostigmin 2.5 Injection unless your doctor advises you to do so -
Is this Myostigmin 2.5 Injection habit forming or addictive?
Myostigmin 2.5 Injection is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Myostigmin 2.5 Injection. So it is best to avoid driving.
Is it safe?
There are no side effects of Myostigmin 2.5 Injection, so it is safe for use.
Is it able to treat mental disorders?
There is no benefit of taking Myostigmin 2.5 Injection for mental disorders.
Interaction between Food and Myostigmin 2.5 Injection
You can take Myostigmin 2.5 Injection with food.
Interaction between Alcohol and Myostigmin 2.5 Injection
Chances of side effects of drinking alcohol while taking Myostigmin 2.5 Injection are low. If you feel any adverse effects, please seek medical advice as soon as possible.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bloxiverz™ (Neostigmine Methylsulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 107
